To outline key evidence-based resources that inform neurologic care.
Approach:
AHA/ASA Primary Prevention of Stroke Guideline: Offers recommendations for first-stroke prevention through risk factor management, cardiovascular and brain health optimization, and lifespan-based strategies, with updated guidance on sex-specific stroke risk factors.
Dopaminergic Therapy for Early Parkinson Disease Guideline: Recommends initiating dopaminergic treatment for motor symptoms in early Parkinson disease, comparing levodopa, dopamine agonists, and related formulations, and supporting clinician-patient discussions about expected motor benefit, dyskinesia risk, impulse control disorders, prescribing decisions, and safety monitoring.
International League Against Epilepsy Classification: Organizes epilepsy diagnosis by seizure type, epilepsy type, and syndrome, incorporating etiology at each stage of evaluation to aid in treatment decisions.
Key Findings:
AHA/ASA guidelines provide comprehensive stroke management recommendations, including updated guidance on sex-specific stroke risk factors.
NIH Stroke Scale is a validated tool for assessing stroke severity.
Dopaminergic therapy guidelines support informed treatment decisions in Parkinson disease, emphasizing safety monitoring.
Anti-amyloid monoclonal antibodies show promise for early Alzheimer disease.
Calcitonin gene-related peptide therapies are effective for migraine prevention.
Interpretation:
The article summarizes essential guidelines and tools that enhance neurologic care based on current evidence.
Conclusion:
The framework serves as a reference for clinicians in neurology.
